QPCR showed a trend of reduced Slc46a1 transcript levels in KO compared to WT antNPCs that reached borderline significance ( P ≤ 0.07), supported by a Western blot analysis that revealed notable loss in PCFT protein expression in Tet1 KO cells (Fig. 6C,D ).
One sample two-tailed t tests showed a trend that the initial performance of the control group was above chance level (i.e., 0.25), t = 1.86, df = 27, p = .07.
However, it is worth mentioning that our data showed a trend towards signification between these two groups ( p = 0.070).
Walnut consumption significantly decreased the nuclear ChREBP protein level in control rats (C vs CW, p < 0.001) and showed a trend toward an increase in the cytosolic ChREBP protein level of control rats (C vs CW, p = 0.07).
NAC mice showed a trend for improvement in comparison to PBS-treated mice ( p = 0.07; Fig. 8 a).
Western blotting showed a band corresponding to the predicted 43‐kDa molecular weight for asporin in rToF‐PVR samples and showed a trend toward increased expression ( P =0.07) compared with RV donor samples.
COX-EGFR Regression analysis between COX-1 mRNA and EGFR mRNA showed a trend to significance in tumor tissue (p < 0.07).
A higher level of education showed a trend toward a positive association (p = 0.07) with some physical indexes on the SF-36 questionnaire (PCS, PF, and BP).
Low baseline tumor infiltrating CD20+ B cells showed a trend towards association with worse clinical response (p = 0.07; N = 24).
Patients on biologic therapy reported dyspnea less frequently (biologic 1/25, 4.0%; nonbiologic 23/110, 20.9%, P = .04) but showed a trend toward increased HS flares (biologic 12/25, 48.0%; nonbiologic 32/110, 29.4%, P = .07) and longer time to COVID-19 resolution (biologic: median (interquartile range) 21 (14-31) days; nonbiologic: 14 (9-25) days, P = .07).
The sum of all secretory membranes (TV + CAM + BLM) showed a trend to increase in WT animals in which acid secretion was inhibited (26.8 ± 1.1 versus 31.8 ± 2.5 P = .07), showing inequitable exchange, due in large part to a relatively greater increase in TV.
Compared with DES, patients treated with BVS showed a trend towards an increase in the risk of MI (125 events in those assigned to BVS and 50 to DES; OR 1.36; CI 0.97 to 1.91; I 2 =0%; p=0.07) (p=0.06 by fixed-effect model)) ( figure 1 C).
ANRIL Gene Polymorphisms The estimated haplotype T A A A (corresponding to SNPs rs1333045, rs1333048, rs4977574, and rs10757278) showed a trend toward higher prevalence in autism cases compared to controls (OR (95% CI) = 1.77 (1.19–2.64), adjusted P = 0.07).
The composite biomarker was prognostic for progression in the 177 Lu + SBRT group (time ratio [TR], 1.8 [95% CI, 1.21 to 2.66]; P = .0037; Fig 3 C) and showed a trend in the SBRT group (TR, 1.6 [95% CI, 0.96 to 2.66]; P = .07; Fig 3 D).
In a correlation analysis, CD4 + TNFa + significantly correlated with the mean increase in antibody titers after the vaccine boost (correlation coefficient, 0.58; P = .029), and correlation of CD4 + INFγ + with mean antibody increase showed a trend toward statistical significance (correlation coefficient, 0.49; P = .07).
Indeed, in a meta-analysis of almost 29,000 patients with COVID-19, use of RAAS inhibitors for any condition showed a trend to lower risk of death or critical events (odds ratio 0.67, 95% CI 0.43 to 1.03, p = 0.07).
Unemployed participants showed a trend toward lower odds of migraine compared to employed individuals (OR = 0.88, 95% CI [0.77, 1.01], P = .07).
In addition, two-way ANOVA showed a trend for condition x set interaction ( p = 0.07, η 2 = 0.12).
The mOS was similar for all genotypes in the PANGEA cohort, while the non-PANGEA cohort showed a trend towards prolonged survival in the non-F/F subgroup (mOS 43.4 versus 23.1 months, P = 0.07; Figure 2 A-C; Table 2 ).
First, we looked at CR/CRi status at FU90 and found a trend for an association of chromatin-modifier mutations with a higher CR/CRi rate ( p = 0.07), whereas mutations in tumor-suppressor genes showed a trend for a lower CR/CRi rate ( p = 0.07) ( Supplementary Table S4 ).
Chest pain showed a trend to be more prevalent among patients with than without mitral annulus disjunction (43% vs 12%; p = 0.07).
The Bonferroni corrected post hoc Wilcoxon tests showed a trend ( p = 0.07) for a higher median score during BP stimulation compared to the WN stimulus responses.
The Shannon diversity index showed a trend towards an increased bacterial diversity in the non-secretor individuals (p = 0.07).
At 2 h post ingestion, CHQ showed a trend for increased S6K1 phosphorylation of P = 0.07 compared to baseline (Fig. 4 B). 4E-BP1 (Thr37/46) phosphorylation was significantly increased ( P < 0.05) at 1 h post ingestion in both groups compared to baseline.
CRLB of metabolites that were significantly different or showed a trend between the two groups are marked with *p<0.07, **p<0.001.